These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1583259)
21. [Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects]. Villani P; Cocchi L; Giacchino R; Seminari E; Regazzi MB; Maserati R Clin Ter; 1996 Jun; 147(6):279-93. PubMed ID: 8925637 [TBL] [Abstract][Full Text] [Related]
22. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. Lederman HM; Williams PL; Wu JW; Evans TG; Cohn SE; McCutchan JA; Koletar SL; Hafner R; Connick E; Valentine FT; McElrath MJ; Roberts NJ; Currier JS; J Infect Dis; 2003 Dec; 188(12):1794-803. PubMed ID: 14673757 [TBL] [Abstract][Full Text] [Related]
23. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus. Popa LG; Popa MI; Zaharia A; Ocneanu M Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456 [TBL] [Abstract][Full Text] [Related]
24. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment]. Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G Sante; 1999; 9(5):293-300. PubMed ID: 10657773 [TBL] [Abstract][Full Text] [Related]
25. [Several aspects of HIV infections]. Costantino M Minerva Chir; 1991 Oct; 46(20):1152. PubMed ID: 1766567 [No Abstract] [Full Text] [Related]
26. A brighter future for the AIDS patient. Lowell E; Van Tassell B Insight; 2002; 27(4):95-6. PubMed ID: 12520982 [TBL] [Abstract][Full Text] [Related]
27. Selected open clinical trials for HIV/AIDS treatments. Vega G BETA; 1995 Dec; ():55-8. PubMed ID: 11363012 [TBL] [Abstract][Full Text] [Related]
28. Therapy of acquired immunodeficiency syndrome. Yarchoan R; Masur H; Broder S Cancer Chemother Biol Response Modif; 1987; 9():200-25. PubMed ID: 3079403 [No Abstract] [Full Text] [Related]
29. Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management. Pahwa S Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S61-71. PubMed ID: 3041360 [TBL] [Abstract][Full Text] [Related]
30. Early antiretroviral treatment of HIV not found beneficial. Todays OR Nurse; 1994; 16(4):58. PubMed ID: 8066597 [No Abstract] [Full Text] [Related]
31. Antiretroviral drug treatment for HIV/AIDS. Goldschmidt RH; Moy A Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838 [TBL] [Abstract][Full Text] [Related]
32. Are we winning the battle against the human immunodeficiency virus. Sullivan AK; Nelson MR Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):486-8. PubMed ID: 10193449 [No Abstract] [Full Text] [Related]
33. AIDS. Treatment strategies and the Minnesota AIDS Clinical Trials Unit. Thurn JR; Henry K; Balfour HH Minn Med; 1988 May; 71(5):289-92. PubMed ID: 2841562 [No Abstract] [Full Text] [Related]
35. [An important task even in the HAART era (High Activity Anti-Retroviral Therapy). Infection management in HIV-patients]. Internist (Berl); 1999 Mar; 40(3 Suppl Infektions):1-4. PubMed ID: 10202682 [No Abstract] [Full Text] [Related]
36. Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients. Ting PT; Koo JY Int J Dermatol; 2006 Jun; 45(6):689-92. PubMed ID: 16796629 [TBL] [Abstract][Full Text] [Related]
37. [Staying on antiviral treatment of HIV-infected children]. Vaudre G; Martelet S; Dollfus C Soins Pediatr Pueric; 2000; (194):29-31. PubMed ID: 11190173 [No Abstract] [Full Text] [Related]
38. Gastrointestinal mucosal biopsy in HIV disease and AIDS. Cranston RD; Anton PA; McGowan IM Gastrointest Endosc Clin N Am; 2000 Oct; 10(4):637-67, vi. PubMed ID: 11036537 [TBL] [Abstract][Full Text] [Related]
39. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763 [TBL] [Abstract][Full Text] [Related]
40. [Effect of opportunistic infections on the frequency of leukocyte subpopulations from type-1 human immunodeficiency virus infected individuals]. Ramírez Z; Cataño JC; Román A; Rugeles MT; Montoya CJ Biomedica; 2008 Mar; 28(1):64-77. PubMed ID: 18645662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]